Analyst Recommendations

Macquarie analyst issues OUTPERFORM recommendation for MSFT on April 2, 2024 09:07AM ET. The previous analyst recommendation was Outperform.MSFT was trading at $419.7703 at issue of the analyst...

April 2, 2024   MSFT 0.22%

Susquehanna analyst issues POSITIVE recommendation for TSM on April 2, 2024 07:06AM ET. The previous analyst recommendation was Positive.TSM was trading at $141.49 at issue of the analyst...

April 2, 2024   TSM -1.24%

Barclays analyst issues OVERWEIGHT recommendation for TSM on April 2, 2024 05:30AM ET. The previous analyst recommendation was Overweight.TSM was trading at $141.49 at issue of the analyst...

April 2, 2024   TSM -1.24%

Barclays analyst issues UNDERWEIGHT recommendation for NIO on April 2, 2024 06:07AM ET. The previous analyst recommendation was Overweight.NIO was trading at $4.64 at issue of the analyst...

April 2, 2024   NIO -4.47%

Wolfe Research analyst issues BUY recommendation for C on April 1, 2024 05:00PM ET. The previous analyst recommendation was Buy.C was trading at $63.46 at issue of the...

April 1, 2024   C -0.27%

Susquehanna analyst issues UNDERPERFORM recommendation for SLB on April 1, 2024 04:00PM ET. The previous analyst recommendation was Underperform.SLB was trading at $55.22 at issue of the analyst...

April 1, 2024   SLB -0.69%

Wells Fargo analyst issues BUY recommendation for SLB on April 1, 2024 04:00PM ET. The previous analyst recommendation was Buy.SLB was trading at $55.22 at issue of the...

April 1, 2024   SLB -0.69%

Argus Research analyst issues BUY recommendation for CCL on April 1, 2024 12:32PM ET. The previous analyst recommendation was Buy.CCL was trading at $16.0899 at issue of the...

April 1, 2024   CCL 0.34%

Morgan Stanley analyst issues OVERWEIGHT recommendation for LI on April 1, 2024 09:29AM ET. The previous analyst recommendation was Overweight.LI was trading at $30.88 at issue of the...

April 1, 2024   LI 1.84%

Morgan Stanley analyst issues OVERWEIGHT recommendation for XPEV on April 1, 2024 09:28AM ET. The previous analyst recommendation was Overweight.XPEV was trading at $7.75 at issue of the...

April 1, 2024   XPEV -2.45%